Your browser doesn't support javascript.
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection.
Gittelman, Rachel M; Lavezzo, Enrico; Snyder, Thomas M; Zahid, H Jabran; Carty, Cara L; Elyanow, Rebecca; Dalai, Sudeb; Kirsch, Ilan; Baldo, Lance; Manuto, Laura; Franchin, Elisa; Del Vecchio, Claudia; Pacenti, Monia; Boldrin, Caterina; Cattai, Margherita; Saluzzo, Francesca; Padoan, Andrea; Plebani, Mario; Simeoni, Fabio; Bordini, Jessica; Lorè, Nicola I; Lazarevic, Dejan; Cirillo, Daniela M; Ghia, Paolo; Toppo, Stefano; Carlson, Jonathan M; Robins, Harlan S; Crisanti, Andrea; Tonon, Giovanni.
  • Gittelman RM; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Lavezzo E; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Snyder TM; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Zahid HJ; Microsoft Research, Redmond, Washington, USA.
  • Carty CL; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Elyanow R; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Dalai S; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Kirsch I; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Baldo L; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Manuto L; Adaptive Biotechnologies, Seattle, Washington, USA.
  • Franchin E; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Del Vecchio C; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Pacenti M; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Boldrin C; Azienda Ospedale Padova, Microbiology and Virology Unit, Padua, Italy.
  • Cattai M; Azienda Ospedale Padova, Microbiology and Virology Unit, Padua, Italy.
  • Saluzzo F; Azienda Ospedale Padova, Microbiology and Virology Unit, Padua, Italy.
  • Padoan A; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Plebani M; Department of Medicine, University of Padova, Padua, Italy.
  • Simeoni F; Department of Medicine, University of Padova, Padua, Italy.
  • Bordini J; Center for Omics Sciences and.
  • Lorè NI; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Lazarevic D; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Cirillo DM; Center for Omics Sciences and.
  • Ghia P; Division of Immunology, Transplantation and Infectious Disease, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Toppo S; Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Carlson JM; Vita-Salute San Raffaele University, Milan, Italy.
  • Robins HS; Department of Molecular Medicine, University of Padova, Padua, Italy.
  • Crisanti A; CRIBI Biotech Center, University of Padova, Padua, Italy.
  • Tonon G; Microsoft Research, Redmond, Washington, USA.
JCI Insight ; 7(10)2022 05 23.
Article in English | MEDLINE | ID: covidwho-1794307
ABSTRACT
T cells play a prominent role in orchestrating the immune response to viral diseases, but their role in the clinical presentation and subsequent immunity to SARS-CoV-2 infection remains poorly understood. As part of a population-based survey of the municipality of Vo', Italy, conducted after the initial SARS-CoV-2 outbreak, we sampled the T cell receptor (TCR) repertoires of the population 2 months after the initial PCR survey and followed up positive cases 9 and 15 months later. At 2 months, we found that 97.0% (98 of 101) of cases had elevated levels of TCRs associated with SARS-CoV-2. T cell frequency (depth) was increased in individuals with more severe disease. Both depth and diversity (breadth) of the TCR repertoire were positively associated with neutralizing antibody titers, driven mostly by CD4+ T cells directed against spike protein. At the later time points, detection of these TCRs remained high, with 90.7% (78 of 96) and 86.2% (25 of 29) of individuals having detectable signal at 9 and 15 months, respectively. Forty-three individuals were vaccinated by month 15 and showed a significant increase in TCRs directed against spike protein. Taken together, these results demonstrate the central role of T cells in mounting an immune defense against SARS-CoV-2 that persists out to 15 months.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Jci.insight.151849

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Jci.insight.151849